Vancouver, British Columbia--(Newsfile Corp. - March 23, 2018) - Alliance Growers Corp. (CSE: ACG) (FSE: 1LA) (WKN:
A2DFYX) ("Alliance Growers" or the "Company") applauds the landmark decision for advancing the bill to legalize
recreational marijuana passing a key legislative stage in the Senate. Senators have voted to pass the Liberal government's
marijuana legalization legislation, Bill C-45, at second reading. Prime Minister of Canada Justin Trudeau stated his support for
the bill, saying "the current system does not work" because Canadian youth are the highest users of marijuana in the world even
though recreational use is banned by law.
Commenting on the landmark decision toward the passing of the bill for the legalization of recreational marijuana, Alliance
Growers President and CEO, Dennis Petke stated, "We are thrilled with the positive vote passed by the senate toward the bill to
legalize recreational marijuana. Alliance Growers is well positioned to take full advantage of the coming legislation. This
significant milestone, puts Alliance Growers and Pharmagreen and our Cannabis Botany Center at the forefront of the Cannabis
Industry. The advantages of legalization are that it opens a retail market in addition to a medical market, loosens
regulatory restrictions for access, expands distribution and expands the industry into the billions of dollars. The cannabis
industry will now evolve at a very quick pace. Today's decision is another step forward for our Company as we continue to
take Alliance Growers to where the cannabis market is going and not where it is today."
The decision for advancing the bill to legalize recreational marijuana passing a key legislative stage in the Senate will have
tremendous positive impact on many of Alliance Growers' businesses:
Cannabis Botany Centre
These expanded market conditions provide increased demand for the product and services offered in the Cannabis Botany Center
which translates into more sales, which translates into significant profits and therefore increased value for all shareholders of
the Company. On a global scale it opens Canada to take the lead in the Cannabis Industry and for Canadian companies to set
precedence as potential global suppliers of products, services and technologies.
The expansion of building state-of-the-art greenhouses will provide strong additional revenues for the joint venture between
Alliance and Pharmagreen. The greenhouses will be focused on significant quantities of production of the tissue cultured,
proprietary "CBD Dana" hemp strain to supply retail Canadian, Cannabis CBD markets as well as for worldwide export.
Investment in New Maple Holdings
With the Company's strategic investment in Canwe, Alliance Growers has an entry into the lucrative Ontario cannabis market for
both medical and recreational marijuana. Canwe has access to a 22-acre property approximately 1.5 hours away from Toronto that it
plans to use as its state-of-the-art hydroponic growing facility. Canwe boasts a dedicated team of highly sought-after industry
veterans, some of whom formerly worked at ACMPR-licensed MedReleaf Corp. The team also includes several University of Toronto
alumni and quality assurance specialists from the food industry. Canwe plans to construct an initial 80,000 square foot
purpose-built and cutting-edge cultivation centre, with the potential to expand the centre to 200,000 square feet over two floors.
Like the Alliance Growers' Cannabis Botany Centre, Canwe will have expanded market conditions for its products and services and
enjoy the benefit of being in Canada's most populous province, Ontario and near Canada's largest city, Toronto.
Acquisition of the Quebec late-stage ACMPR applicant, Biocannatech
Quebec's ACMPR licenses are currently under-represented relative to other provinces in Canada. Management of Alliance Growers
believes it is advantageous to capitalize on the mandate to increase the number of ACMPR licensed companies in Quebec. We are
pleased to have now entered the grow space in Quebec as we negotiate additional license applicants in this province. In addition to
growing, we look forward to becoming a preferred tissue cultured plantlet supplier to the Quebec ACMPR community. The
legislative move toward the legalization of recreational marijuana will massively enhance the value of a ACMPR, especially in the
province of Quebec. With strong partners in Quebec, Canada's second most populous province, Alliance Growers is well positioned to
take advantageous of opportunities in both recreational and medical marijuana in the province.
About Alliance Growers
Alliance Growers is a diversified cannabis company driven by the Company's 'Four Pillars' Organization Plan — Cannabis Botany
Centre, Strategic ACMPR Investments, CBD Oil Supply and Distribution, and Research and Development.
Alliance Growers has finalized its a new business partnership with WFS Pharmagreen Inc., to jointly develop and operate a
40,000-square foot facility to be the first of its kind in Western Canada to house a DNA Botany lab, extraction facility and Tissue
Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The proposed Cannabis Botany
Centre will grow Cannabis plantlets using proprietary tissue culture propagation, specifically the "Chibafreen Invitro Plant
Production System", which assures consistent composition and purity of each plantlet for the growers.
Alliance Growers has entered into an exclusive agreement to acquire a late stage licensed producer applicant, Biocannatech, to
become a licensed producer under Health Canada's access to cannabis for medical purposes regulations ("ACMPR") in Quebec. Alliance
Growers will supply financing and resources to build out the medical marijuana facility in preparation for the inspection required
to obtain a growing license. Once Health Canada is satisfied with a successful crop, Alliance Growers will be granted its
distribution license. This acquisition allows the Company an opportunity to become a licensed producer in the Province of Quebec
and gain an in-road to provide tissue culture plantlets to all licensed producers in Quebec.
Further, Alliance Growers has been negotiating to obtain other exclusive Canadian distribution agreements for certain
proprietary products for support of the Cannabis growing industry in addition to possible partnerships with Licensed Producer
Applicants at various stages in the Health Canada License process.
For further information, please visit the Company's website at www.alliancegrowers.com or the Company's profile at www.sedar.com.
If you would like to be added to Alliance Growers' news distribution list, please send your email address
to newsletter@alliancegrowers.com
On behalf of the board of directors of
ALLIANCE GROWERS CORP.
"Dennis Petke"
Dennis Petke
President and CEO
For more information contact:
Dennis Petke
Tel: 778-331-4266
DennisPetke@alliancegrowers.com
Rob Grace
Communications Consultant
Tel: 778-998-5431
RobDGrace@gmail.com
THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS
RELEASE.
FORWARD LOOKING INFORMATION
This news release contains forward-looking statements and forward-looking information within the meaning of applicable
securities laws. These statements relate to future events or future performance. All statements other than statements of historical
fact may be forward-looking statements or information. More particularly and without limitation, the news release contains
forward-looking statements and information relating to Company's corporate strategy. The forward-looking statements and information
are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the
Company's ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions
on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the
forward-looking statements and information since no assurance can be given that they will prove to be correct.
Forward-looking statements and information are provided for the purpose of providing information about the current expectations
and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and
information may not be appropriate for other purposes, such as making investment decisions. Since forward-looking statements and
information address future events and conditions, by their very nature they involve risks and uncertainties. Actual results could
differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the
Company's ability to identify and complete additional suitable acquisitions to further the Company's growth as well as risks
associated with the medical marijuana industry in general, such as operational risks in development and production delays or
changes in plans with respect to development projects or capital expenditures; the uncertainty of the capital markets; the
uncertainty of receiving the required licenses, production, costs and expenses; health, safety and environmental risks; marketing
and transportation; loss of markets; environmental risks; competition; incorrect assessment of the value of the potential market;
ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals
and changes in legislation, including but not limited to tax laws and regulated regulations. Accordingly, readers should not place
undue reliance on the forward-looking statements, timelines and information contained in this news release. Readers are cautioned
that the foregoing list of factors is not exhaustive.
The forward-looking statements and information contained in this news release are made as of the date hereof and no undertaking
is given to update publicly or revise any forward-looking statements or information, whether as a result of new information, future
events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking
statements or information contained in this news release are expressly qualified by this cautionary statement.